ACB stock is lower by 2% Friday as the cannabis stock decreases $0.01 and underperforms the market. Aurora Cannabis Inc (ACB) is around the bottom of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. ACB received an overall rating of 23, which means that it scores higher than 23 percent of all stocks. Aurora Cannabis Inc also achieved a score of 26 in the Drug Manufacturers - Specialty & Generic industry, putting it above 26 percent of Drug Manufacturers - Specialty & Generic stocks. Drug Manufacturers - Specialty & Generic is ranked 118 out of the 148 industries.
News Home
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
Bottom Rated Cannabis Stock in the Drug Manufacturers - Specialty & Generic Industry Drops -2% Friday; Is it Time to Sell Aurora Cannabis Inc (ACB)?
Mentioned in this article
ACB has an Overall Score of 23. Find out what this means to you and get the rest of the rankings on ACB!